BRO · Q2 2025 Earnings
CautiousBrown & Brown
Reported July 28, 2025
30-second summary
Brown & Brown printed 9.1% YoY revenue growth to $1.285B, but organic growth slowed to 3.6% as admitted rates dropped to +1–5% (vs. +5–10% a year ago) and June showed further deceleration within the quarter. Adjusted EBITDAC margin expanded 100bps to 36.7%, helped by ~$13M of incremental interest income from offering proceeds held pending the Accession close (non-recurring at that magnitude); a separate contingent commission true-up specifically aided the Programs segment margin (52.8%, +320bps). The Accession (RSC Topco) acquisition — which includes Risk Strategies and 180 as underlying businesses — closes August 1 with synergies targeted over 3.5 years; that's the operating story for the back half.
Headline numbers
EPS
Q2 FY2025
$1.03
Revenue
Q2 FY2025
$1.28B
+9.1% YoY
Operating margin
Q2 FY2025
24.2%
Key financials
Q2 FY2025| Metric | Q2 FY2025 | YoY |
|---|---|---|
| Revenue | $1.28B | +9.1% |
| EPS | $1.03 | — |
| Operating margin | 24.2% | — |
Guidance
Prior quarter data unavailable — comparison not possible.
Segment performance
Q2 FY2025| Segment | Q2 FY2025 | YoY |
|---|---|---|
| Commissions and fees | $1.249B | +8.2% |
Other KPIs
Q2 FY2025| Segment | Q2 FY2025 |
|---|---|
| Organic Revenue Growth | 3.6% |
| EBITDAC - Adjusted | $471 million |
| EBITDAC Margin - Adjusted | 36.7% |
| Income Before Income Taxes Margin | 24.2% |
Management tone
Management's posture is forward-leaning despite the organic miss — they framed Q2 as a normalization, not a deterioration, and pivoted attention to Accession integration as the operating priority for the next 12 months.
Macro framing shifted from passive waiting to active anticipation of forced spending. The pre-call assumption had been that tariff uncertainty would keep customers on the sidelines. This quarter's framing is different: "With continued economic and job expansion, we think some customers will more than likely only be able to delay their investment decisions for so long." Management is now betting that the delay window closes within a few quarters and is positioning organic growth to re-accelerate off pent-up demand rather than rate.
The pricing narrative bifurcated. A quarter ago this was a "broad rate moderation" story; now management distinguishes softening admitted lines from resilient specialty lines and is calling out arbitrage between renewal and new-business quotes: "carriers can have a material difference in quoted rates for renewal business versus new business on similar insured assets." That's a setup for share-shift opportunity, not commoditization — but it also means the easy rate tailwind that lifted organic in 2022–2024 is gone and the team has to work harder for each point of growth.
Accession moved from "future potential" to "operational readiness." Management confirmed substantially all approvals, an August 1 close, and a 3.5-year synergy timeline. The tone on leverage was unapologetic: "Our balance sheet is in great shape, and we have strong cash flows to support de-levering post-closing, which is consistent with our historical approach." This is the dominant story for the back half — if integration slips, the bull case slips with it.
Customer behavior commentary turned more granular. Last cycle, management talked about price sensitivity as a top-line headwind. This quarter the framing is sharper: customers in admitted lines are "pocketing the savings" from rate declines, while non-admitted customers are buying higher limits or deductible buy-downs. That partially offsets the premium decline but doesn't fully replace it — which is why organic landed at 3.6% rather than the mid-single-digit pace investors had modelled.
Recurring themes management leaned on this quarter:
Risks management surfaced:
Q&A highlights
Mark Hughes · Truist Securities
Asked about retail organic growth discrepancies versus consensus expectations in Q2, specifically what fluctuations occurred and outlook for Q3.
Management attributed over half the discrepancy to downward rate pressure, with the remainder due to lower new business. Indicated good visibility into Q3 with strong pipeline, characterizing quarterly variations as normal.
Gregory Peters · Raymond James
Requested visibility on Ascension Risk Strategies and 180 integration financials, timing of synergies realization, and organic growth profile assessment after increased due diligence.
Confirmed 3.5-year synergy capture timeline unchanged. Praised talent and underwriting discipline in both businesses. Explained $750M set-aside for discontinued operations in runoff. Stated 180 and Risk Strategies' growth profiles are substantially similar to core Brown & Brown over time.
Mike Zuremski · BMO
Asked whether organic growth deceleration reflects unusual market dynamics or classic market cycle, and whether casualty softening is broader than historical norms.
Management characterized as classic market cycle, not unusual. Clarified casualty pricing won't accelerate as quickly (not negative). Attributed pressure to carriers covering reinsurance commitments in property soft market. Noted current rate changes (1-5% vs prior 5-10%) return to historical norms post-COVID abnormalities.
Elise Greenspan · Wells Fargo
Sought clarification on retail segment full-year guidance given Q2 miss, property rate deceleration impact, and whether slowdown accelerated in June.
Reiterated investor must factor continued rate deceleration into Q3/Q4 organic expectations. Confirmed June showed further deterioration versus April/May. Explained a contingent commission true-up benefited Q2 margins.
Meyerfields · KBW
Requested updated split between economic growth and pricing as drivers of organic growth post-Ascension integration, and whether there is a quantitative threshold triggering management concern on underperformance.
Deferred specific update pending Ascension integration but indicated core middle-market business maintains 2/3 economic growth, 1/3 pricing. Programs more rate-driven due to cat concentration. Declined to set numeric threshold for concern, emphasizing long-term consistency and that one quarter doesn't make a trend.
What to watch into next quarter
Organic growth ex-Accession in Q3. Q2 printed 3.6%. With June trending weaker and admitted rates still moderating, Q3 organic below 3% would suggest the deceleration is more than cyclical normalization.
Adjusted EBITDAC margin run-rate as the interest-income tailwind rolls off. Q2's 100bps expansion benefited from ~$13M of incremental interest income on proceeds from the June equity and debt issuances, held pending the Accession close. Once those proceeds are deployed into the acquisition, that tailwind compresses — watch whether the underlying margin can hold without it.
Accession close date and integration milestones. Anticipated August 1 close. Any slip, or a Q3 print that flags integration friction or revenue dis-synergies, materially damages the H2 thesis.
Property rate trajectory through hurricane season. Management expects cap property rates to keep declining in Q3/Q4 "subject to" hurricane season. A major Atlantic event could halt the decline; an inactive season accelerates softening.
New business momentum vs. rate-driven growth. Over half the Q2 organic miss was rate, but the rest was lower new business. Whether new business stabilizes — independent of rate — is the cleaner read on competitive positioning.
Sources
- Brown & Brown Q2 2025 Press Release / 8-K Exhibit 99.1 — https://www.sec.gov/Archives/edgar/data/79282/000095017025099237/bro-ex99_1.htm
- Brown & Brown Q2 2025 earnings call commentary (prepared remarks and Q&A)
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.